Immuneering PEG Ratio

Immuneering (IMRX) currently reports a PEG ratio of -21.92. That is below the Healthcare sector average of 3.22. Use the charts on this page to explore Immuneering's PEG ratio history and peer comparisons.

Immuneering's PEG ratio of -21.92 is lower than the Healthcare sector average of 3.22. That is roughly 780.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Immuneering's market price to a fundamental measure such as earnings, sales, or book value. At -21.92, IMRX can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of -21.92, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 3.22. From there, open related valuation or income-statement pages for Immuneering, and consider following IMRX for alerts when major investors trade the stock.

Immuneering is classified in the Healthcare sector. On PEG ratio, it currently shows -21.92 versus a sector average near 3.22. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IMRX with unrelated industries.